Clinical trial · Interventional
Fluorescence-guided Resection in Breast Cancer
Evaluation of the Suitability of PD L 506 for Intraoperative Visualisation of Palpable and Nonpalpable Breast Cancer Tissue
NCT01110954CI-TRIAL-00026753terminatedPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Insufficient recruitment
Summary
Brief summary (as posted)
This is an explorative phase II study to investigate the suitability of PD L 506 in the specific intra-operative detection of breast tumour tissue.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Tumour | Breast Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| PD L 506 | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- PD L 506 2nd dose
- description
- Different dosage
- interventionNames
- Drug: PD L 506
- type
- EXPERIMENTAL
- label
- PD L 506
- interventionNames
- Drug: PD L 506
Primary outcomes (1)
- measure
- Fluorescence intensity in breast cancer tissue
- timeFrame
- 3 h after intake of study medication
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Written informed consent * Caucasian female postmenopausal patients * Patients with histologically confirmed primary palpable and nonpalpable breast cancer sized up to 5 cm (T1 - T2) Exclusion Criteria: * Suspicious lymphogenic metastases (cN1-3) * Acute or chronic hepatic diseases * Manifest renal diseases with renal dysfunction * Relevant cardiac disease * Preceding therapy of breast tumour under investigation * Patients with multiple attempts of hook-wire placement in preparation of surgery * Dementia or psychic condition that might interfere with the ability to understand the study and thus give a written informed consent * Simultaneous participation in another clinical study or participation in another clinical study in the 30 days directly preceding treatment
References
Publications (0)
Data not yet available
No reference posted for this study.